We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

Fund managers haven’t disclosed any holdings of MNTA yet.

MNTA Hedge Fund Activity: Q4 2021 in Review

0 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2021, worth a combined $0 — down 100% from $116K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of MNTA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Neo Ivy Capital Management, exiting entirely with an estimated $116K sold.

  • 0 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2021, down from 1 in Q3 2021.
  • Funds reported $0 of Momenta Pharmaceuticals, Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2021 and 1 closed out, a net change of -1 holder.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q4 2021 was Neo Ivy Capital Management, an estimated $116K sold.

Based on aggregated 13F filings for Q4 2021.